{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:42:44Z","timestamp":1788633764236,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,29]]},"DOI":"10.7759\/cureus.44317","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T08:15:40Z","timestamp":1693296940000},"source":"Crossref","is-referenced-by-count":4,"title":["Fluid Resuscitation in Septic Patients"],"prefix":"10.7759","author":[{"given":"Shahid","family":"Qayyum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2022.61.s1.11","article-title":"Sepsis definition: what's new in the treatment guidelines","volume":"61","author":"Srzi\u0107 I","year":"2022","unstructured":"Srzi\u0107 I, Nesek Adam V, Tunji\u0107 Pejak D. Sepsis definition: what's new in the treatment guidelines. Acta Clin Croat. 2022, 61:67-72. 10.20471\/acc.2022.61.s1.11","journal-title":"Acta Clin Croat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","volume":"34","author":"Rello J","year":"2017","unstructured":"Rello J, Valenzuela-S\u00e1nchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: a review of advances in management. Adv Ther. 2017, 34:2393-411. 10.1007\/s12325-017-0622-8","journal-title":"Adv Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2018.03.039","article-title":"Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial","volume":"72","author":"Self WH","year":"2018","unstructured":"Self WH, Semler MW, Bellomo R, et al.. Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial. Ann Emerg Med. 2018, 72:457-66. 10.1016\/j.annemergmed.2018.03.039","journal-title":"Ann Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.13356","article-title":"Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults","volume":"308","author":"Yunos NM","year":"2012","unstructured":"Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012, 308:1566-72. 10.1001\/jama.2012.13356","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318256be72","article-title":"A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte\u00ae 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers","volume":"256","author":"Chowdhury AH","year":"2012","unstructured":"Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte\u00ae 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012, 256:18-24. 10.1097\/SLA.0b013e318256be72","journal-title":"Ann Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000239119.57544.0C","article-title":"Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study","volume":"34","author":"Dubois MJ","year":"2006","unstructured":"Dubois MJ, Orellana-Jimenez C, Melot C, et al.. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006, 34:2536-40. 10.1097\/01.CCM.0000239119.57544.0C","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003779","article-title":"The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study","volume":"47","author":"Corl KA","year":"2019","unstructured":"Corl KA, Prodromou M, Merchant RC, et al.. The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study. Crit Care Med. 2019, 47:951-9. 10.1097\/CCM.0000000000003779","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14546","article-title":"Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): a multicenter, randomized feasibility trial","volume":"29","author":"Jessen MK","year":"2022","unstructured":"Jessen MK, Andersen LW, Thomsen MH, et al.. Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): a multicenter, randomized feasibility trial. Acad Emerg Med. 2022, 29:1172-84. 10.1111\/acem.14546","journal-title":"Acad Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro NI","year":"2023","unstructured":"Shapiro NI, Douglas IS, Brower RG, et al.. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023, 388:499-510. 10.1056\/NEJMoa2212663","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock","volume":"386","author":"Meyhoff TS","year":"2022","unstructured":"Meyhoff TS, Hjortrup PB, Wetterslev J, et al.. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022, 386:2459-70. 10.1056\/NEJMoa2202707","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0557OC","article-title":"Balanced crystalloids versus saline in sepsis. a secondary analysis of the SMART clinical trial","volume":"200","author":"Brown RM","year":"2019","unstructured":"Brown RM, Wang L, Coston TD, et al.. Balanced crystalloids versus saline in sepsis. a secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019, 200:1487-95. 10.1164\/rccm.201903-0557OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler MW","year":"2018","unstructured":"Semler MW, Self WH, Wanderer JP, et al.. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018, 378:829-39. 10.1056\/NEJMoa1711584","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.2068","article-title":"Effect of early balanced crystalloids before ICU admission on sepsis outcomes","volume":"159","author":"Jackson KE","year":"2021","unstructured":"Jackson KE, Wang L, Casey JD, Bernard GR, Self WH, Rice TW, Semler MW. Effect of early balanced crystalloids before ICU admission on sepsis outcomes. Chest. 2021, 159:585-95. 10.1016\/j.chest.2020.08.2068","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi P","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, et al.. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014, 370:1412-21. 10.1056\/NEJMoa1305727","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00830-8","article-title":"Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database","volume":"11","author":"Zhou S","year":"2021","unstructured":"Zhou S, Zeng Z, Wei H, Sha T, An S. Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database. Ann Intensive Care. 2021, 11:42. 10.1186\/s13613-021-00830-8","journal-title":"Ann Intensive Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231170778","article-title":"Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: a meta-analysis of randomized clinical trials","volume":"38","author":"Geng L","year":"2023","unstructured":"Geng L, Tian X, Gao Z, Mao A, Feng L, He C. Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: a meta-analysis of randomized clinical trials. J Intensive Care Med. 2023, 38:679-89. 10.1177\/08850666231170778","journal-title":"J Intensive Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.04.036","article-title":"Lower vs higher fluid volumes in adult patients with sepsis: an updated systematic review with meta-analysis and trial sequential analysis","author":"Sivapalan P","year":"2023","unstructured":"Sivapalan P, Ellekjaer KL, Jessen MK, et al.. Lower vs higher fluid volumes in adult patients with sepsis: an updated systematic review with meta-analysis and trial sequential analysis. Chest. 2023, 10.1016\/j.chest.2023.04.036","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5VMR0118-021RR","article-title":"Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality","volume":"104","author":"Frydrych LM","year":"2018","unstructured":"Frydrych LM, Bian G, O'Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018, 104:525-34. 10.1002\/JLB.5VMR0118-021RR","journal-title":"J Leukoc Biol"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.5935\/0103-507X.20190060","article-title":"The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock","volume":"31","author":"Pandompatam G","year":"2019","unstructured":"Pandompatam G, Kashani K, Vallabhajosyula S. The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock. Rev Bras Ter Intensiva. 2019, 31:368-78.","journal-title":"Rev Bras Ter Intensiva"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183464-fluid-resuscitation-in-septic-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:56:17Z","timestamp":1707490577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183464-fluid-resuscitation-in-septic-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.44317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}